Challenge of the Unknown: How Can We Improve Clinical Outcomes in Cancer of Unknown Primary?

J Clin Oncol. 2019 Aug 10;37(23):2089-2090. doi: 10.1200/JCO.19.00449. Epub 2019 Jun 18.

Authors

Alicia-Marie Conway¹, Claire Mitchell¹, Natalie Cook¹

Affiliation

¹ Alicia-Marie Conway, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom, The University of Manchester, Manchester, United Kingdom, and Cancer Research UK Manchester Institute, Manchester, United Kingdom; Claire Mitchell, MD, PhD, The Christie NHS Foundation Trust, Manchester, United Kingdom; and Natalie Cook, MD, PhD, The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.

PMID: 31211603
DOI: 10.1200/JCO.19.00449

No abstract available

Publication types

Letter
Comment

MeSH terms

Carboplatin
Gene Expression Profiling
Humans
Neoplasms, Unknown Primary*
Paclitaxel

Substances

Carboplatin
Paclitaxel